In the present study, the tumor suppressor p53 is mutated in MDA-MB-231 cells [27] and thus, decreased JNK1 activity should attenuate the activity of the JNK1–AP-1–cyclin D1 signaling pathway, resulting in decreased cell proliferation and tumor growth. Here, JUN is linked to neoplasm.